Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1408

1.

Early changes in intramitochondrial cardiolipin distribution during apoptosis.

Garcia Fernandez M, Troiano L, Moretti L, Nasi M, Pinti M, Salvioli S, Dobrucki J, Cossarizza A.

Cell Growth Differ. 2002 Sep;13(9):449-55.

2.

Increased K-ras protein and activity in mouse and human lung epithelial cells at confluence.

Kammouni W, Ramakrishna G, Sithanandam G, Smith GT, Fornwald LW, Masuda A, Takahashi T, Anderson LM.

Cell Growth Differ. 2002 Sep;13(9):441-8.

4.

Early cycling-independent changes to p27, cyclin D2, and cyclin D3 in differentiating mouse embryonal carcinoma cells.

Preclíková H, Bryja V, Pacherník J, Krejcí P, Dvorák P, Hampl A.

Cell Growth Differ. 2002 Sep;13(9):421-30.

5.

Translational regulation of cyclin D1 by 15-deoxy-delta(12,14)-prostaglandin J(2).

Campo PA, Das S, Hsiang CH, Bui T, Samuel CE, Straus DS.

Cell Growth Differ. 2002 Sep;13(9):409-20.

6.

Malignant transformation in human chondrosarcoma cells supported by telomerase activation and tumor suppressor inactivation.

Martin JA, Forest E, Block JA, Klingelhutz AJ, Whited B, Gitelis S, Wilkey A, Buckwalter JA.

Cell Growth Differ. 2002 Sep;13(9):397-407.

7.

Vascular endothelial growth factor and Kaposi's sarcoma cells in human skin grafts.

Samaniego F, Young D, Grimes C, Prospero V, Christofidou-Solomidou M, DeLisser HM, Prakash O, Sahin AA, Wang S.

Cell Growth Differ. 2002 Aug;13(8):387-95.

8.

c-Jun NH(2)-terminal kinase pathway in growth-promoting effect of the G protein-coupled receptor cholecystokinin B receptor: a protein kinase C/Src-dependent-mechanism.

Dehez S, Bierkamp C, Kowalski-Chauvel A, Daulhac L, Escrieut C, Susini C, Pradayrol L, Fourmy D, Seva C.

Cell Growth Differ. 2002 Aug;13(8):375-85.

9.

RhoA biological activity is dependent on prenylation but independent of specific isoprenoid modification.

Solski PA, Helms W, Keely PJ, Su L, Der CJ.

Cell Growth Differ. 2002 Aug;13(8):363-73.

10.

STAT3 activation abrogates growth factor dependence and contributes to head and neck squamous cell carcinoma tumor growth in vivo.

Kijima T, Niwa H, Steinman RA, Drenning SD, Gooding WE, Wentzel AL, Xi S, Grandis JR.

Cell Growth Differ. 2002 Aug;13(8):355-62.

11.
12.

Retinoic acid receptor alpha2 is a growth suppressor epigenetically silenced in MCF-7 human breast cancer cells.

Farias EF, Arapshian A, Bleiweiss IJ, Waxman S, Zelent A, Mira-Y-Lopez R.

Cell Growth Differ. 2002 Aug;13(8):335-41.

13.

Both alpha and beta isoforms of mammalian DNA topoisomerase II associate with chromosomes in mitosis.

Null AP, Hudson J, Gorbsky GJ.

Cell Growth Differ. 2002 Jul;13(7):325-33.

14.

Lack of Fas/CD95 surface expression in highly proliferative leukemic cell lines correlates with loss of CtBP/BARS and redirection of the protein toward giant lysosomal structures.

Monleón I, Iturralde M, Martínez-Lorenzo MJ, Monteagudo L, Lasierra P, Larrad L, Piñeiro A, Naval J, Alava MA, Anel A.

Cell Growth Differ. 2002 Jul;13(7):315-24.

15.

Expression of kinase suppressor of Ras in the normal adult and embryonic mouse.

Giblett SM, Lloyd DJ, Light Y, Marais R, Pritchard CA.

Cell Growth Differ. 2002 Jul;13(7):307-13.

16.

The Wilms' tumor suppressor Wt1 is associated with the differentiation of retinoblastoma cells.

Wagner N, Wagner KD, Schley G, Coupland SE, Heimann H, Grantyn R, Scholz H.

Cell Growth Differ. 2002 Jul;13(7):297-305.

18.

The role of growth factors in the activity of pharmacological differentiation agents.

Matsui WH, Gladstone DE, Vala MS, Barber JP, Brodsky RA, Smith BD, Jones RJ.

Cell Growth Differ. 2002 Jun;13(6):275-83.

19.
20.

Expression profiling of lineage differentiation in pluripotential human embryonal carcinoma cells.

Houldsworth J, Heath SC, Bosl GJ, Studer L, Chaganti RS.

Cell Growth Differ. 2002 Jun;13(6):257-64.

Supplemental Content

Loading ...
Support Center